Followers | 210 |
Posts | 11026 |
Boards Moderated | 1 |
Alias Born | 04/20/2011 |
Friday, November 21, 2014 12:21:24 PM
These developments mean that new markets for cannabis research, medical use, and recreational use will be opening up all the time. It only takes one company as industrious as Cannagrow to seize upon these new markets and elevate share value. Take for example GW Pharmaceuticals (NASDAQ:GWPH), which now trades at 71.34 after successfully developing a portfolio of cannibinoid treatments that includes Sativex, a cannabis-based drug that alleviates spasticity in Multiple Sclerosis and has been shown to help pain symptoms from cancer. Sativex is used in 15 different countries, and it appears to be only a matter of time before it makes its way to the U.S.
I am a trader, only a trader. my posts are my opinion and are
not for sale. I do my DD, I advise you to do yours. My posts
are not recommendations to buy or sell. I have never and
will not accept payment to post on any stock. So don't ask.
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM